Literature DB >> 1571415

Peripheral gangrene associated with Kawasaki disease.

S Tomita1, K Chung, M Mas, S Gidding, S T Shulman.   

Abstract

Three American infants with Kawasaki disease (KD) complicated by peripheral extremity gangrene are reported. Eight such patients (only 1 from Japan) have been reported previously. These 11 patients, infants less than 7 months old at onset of KD, are predominantly non-Asian. At least nine had associated giant coronary aneurysms, and eight had associated peripheral arterial aneurysms. In eight infants the diagnosis of KD was not established and therapy was not instituted until greater than or equal to 14 days after onset. Peripheral ischemia initially was noted 15-31 days after onset. Although the pathogenesis of this complication is not well understood, it likely includes some combination of local peripheral arteritis, arteriospasm, thrombosis peripherally and/or more proximally (e.g., in an axillary artery aneurysm), and cardiogenic shock. Treatment may include use of antiinflammatory agents such as salicylates and intravenous gamma globulin, vasodilative agents and/or methods, and thrombolytic and/or anticoagulant agents in an attempt to prevent the potentially devastating consequences of progressive gangrene.

Entities:  

Mesh:

Year:  1992        PMID: 1571415     DOI: 10.1093/clinids/14.1.121

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  New perspectives in the drug treatment of Kawasaki disease.

Authors:  D Shingadia; S T Shulman
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

2.  Giant coronary artery aneurysms in a Japanese octogenarian - The oldest case of Kawasaki Disease?

Authors:  Stephen G Chun; Jennifer A Armstrong; Derek K Pang; Jeffrey Lau; Ralph V Shohet
Journal:  J Cardiol Cases       Date:  2010-04-01

3.  Combination thrombolytic and anti-platelet therapies in an infant with incomplete kawasaki disease and coronary aneurysms.

Authors:  Peter N Johnson; Robert J Kuhn
Journal:  J Pediatr Pharmacol Ther       Date:  2008-10

4.  Atypical Kawasaki disease with peripheral gangrene and myocardial infarction: therapeutic implications.

Authors:  M von Planta; M Fasnacht; C Holm; S Fanconi; R A Seger
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

5.  Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm.

Authors:  Daiko Wakita; Yosuke Kurashima; Timothy R Crother; Magali Noval Rivas; Youngho Lee; Shuang Chen; Wen Fury; Yu Bai; Shawn Wagner; Debiao Li; Thomas Lehman; Michael C Fishbein; Hal M Hoffman; Prediman K Shah; Kenichi Shimada; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-03       Impact factor: 8.311

Review 6.  Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

7.  Perioperative considerations of kawasaki disease.

Authors:  Lisa To; Stephen T Krazit; Alan D Kaye
Journal:  Ochsner J       Date:  2013

Review 8.  Vasculitis from the pediatric perspective.

Authors:  P A Brogan; M J Dillon
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.686

Review 9.  Aneurysmal coronary artery disease: An overview.

Authors:  Mohamed S ElGuindy; Ahmed M ElGuindy
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

10.  Kawasaki Disease and Peripheral Gangrene in Infancy.

Authors:  Iran Malekzadeh; Vahid Ziaee; Taravat Sadrosadat; Mohammad-Hassan Moardinejad; Keyhan Sayadpour-Zanjani
Journal:  Iran J Pediatr       Date:  2015-12-23       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.